Mami Shibata

531 citations
10 papers · 414 indexed · h-index 9
Topics
Genomics and Rare Diseases (2 papers)Genetics and Neurodevelopmental Disorders (2 papers)Neuroscience and Neuropharmacology Research (2 papers)
Partner nations
JapanUnited StatesFrance

In The Last Decade

Mami Shibata

10 papers receiving 405 citations

Peers

Mami Shibata
Comparison fields: 5 of 67
  • Molecular Biology 283
  • Radiology, Nuclear Medicine and Imaging 140
  • Immunology 102
  • Genetics 59
  • Cellular and Molecular Neuroscience 53
Replace Betty Hom with:
Betty Hom United States
Ai Shintani Japan
Jesse Huang Sweden
Inger Jonasson Sweden
Daopeng Yuan United States
D Stavrou Germany
Hideki Matsuzaki Japan
Debanjan Bhattacharya United States
Injin Bang United States
Redwan Huq United States
Mami Shibata relative to Betty Hom United States Betty Hom's profile →
Citations per field
00.5×7.2×
Betty Hom · 1×
Citations per year

Countries citing papers authored by Mami Shibata

Since Specialization
Citations

This map shows the geographic impact of Mami Shibata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mami Shibata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mami Shibata more than expected).

Fields of papers citing papers by Mami Shibata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mami Shibata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mami Shibata. The network helps show where Mami Shibata may publish in the future.

Co-authorship network of co-authors of Mami Shibata

This figure shows the co-authorship network connecting the top 25 collaborators of Mami Shibata. A scholar is included among the top collaborators of Mami Shibata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mami Shibata. Mami Shibata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 1
2 15
3 17
4 21
5 68
6 9
7 54
8 174
9 18
10 37

About Mami Shibata

Mami Shibata is a scholar working on Immunology and Allergy, Molecular Biology and Cellular and Molecular Neuroscience, having authored 10 papers that have together received 414 indexed citations. Recurring topics across this work include Genomics and Rare Diseases (2 papers), Genetics and Neurodevelopmental Disorders (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (140 citations), Immunology (102 citations) and Molecular Biology (283 citations). Mami Shibata has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Shinichi Hirose, Atsushi Ishii, Shigeru Iida, Naoko Yamane‐Ohnuki, Ryosuke Nakano, Kenya Shitara, Keiichi Yano, Mitsuo Satoh, Masako Wakitani and Hirofumi Misaka. Their work appears in journals such as Journal of Biological Chemistry, Clinical Cancer Research and The Plant Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026